Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.

Chesler L, Weiss WA.

Semin Cancer Biol. 2011 Oct;21(4):245-55. doi: 10.1016/j.semcancer.2011.09.011. Epub 2011 Sep 21. Review.

2.

From fish to FISH: the comparative pathology of neuroblastomas in humans, mice and fish.

Schwab M.

J Cancer Res Clin Oncol. 1999;125(3-4):141-9. Review.

PMID:
10235467
3.

[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].

Pérel Y, Valteau-Couanet D, Michon J, Lavrand F, Coze C, Bergeron C, Notz A, Plantaz D, Chastagner P, Bernard F, Thomas C, Rubie H.

Arch Pediatr. 2004 Jul;11(7):834-42. Review. French.

PMID:
15234382
4.

Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.

Salazar BM, Balczewski EA, Ung CY, Zhu S.

Int J Mol Sci. 2016 Dec 27;18(1). pii: E37. doi: 10.3390/ijms18010037. Review.

5.

Preclinical models for neuroblastoma: establishing a baseline for treatment.

Teitz T, Stanke JJ, Federico S, Bradley CL, Brennan R, Zhang J, Johnson MD, Sedlacik J, Inoue M, Zhang ZM, Frase S, Rehg JE, Hillenbrand CM, Finkelstein D, Calabrese C, Dyer MA, Lahti JM.

PLoS One. 2011 Apr 29;6(4):e19133. doi: 10.1371/journal.pone.0019133.

6.

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.

Gillory LA, Megison ML, Stewart JE, Mroczek-Musulman E, Nabers HC, Waters AM, Kelly V, Coleman JM, Markert JM, Gillespie GY, Friedman GK, Beierle EA.

PLoS One. 2013 Oct 10;8(10):e77753. doi: 10.1371/journal.pone.0077753. eCollection 2013.

7.

Murine models for experimental therapy of pediatric solid tumors with poor prognosis.

Beltinger C, Debatin KM.

Int J Cancer. 2001 May 1;92(3):313-8. Review.

8.

Genetic discoveries and treatment advances in neuroblastoma.

Bagatell R, Cohn SL.

Curr Opin Pediatr. 2016 Feb;28(1):19-25. doi: 10.1097/MOP.0000000000000296. Review.

9.

Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model.

Waldeck K, Cullinane C, Ardley K, Shortt J, Martin B, Tothill RW, Li J, Johnstone RW, McArthur GA, Hicks RJ, Wood PJ.

Int J Cancer. 2016 Jul 1;139(1):194-204. doi: 10.1002/ijc.30056. Epub 2016 Mar 10.

10.

Recent insights into the biology of neuroblastoma.

Schleiermacher G, Janoueix-Lerosey I, Delattre O.

Int J Cancer. 2014 Nov 15;135(10):2249-61. doi: 10.1002/ijc.29077. Epub 2014 Aug 14. Review.

11.

Genetically engineered mouse models of brain cancer and the promise of preclinical testing.

Huse JT, Holland EC.

Brain Pathol. 2009 Jan;19(1):132-43. doi: 10.1111/j.1750-3639.2008.00234.x. Review.

12.

A simple PCR method for rapid genotype analysis of the TH-MYCN transgenic mouse.

Haraguchi S, Nakagawara A.

PLoS One. 2009 Sep 4;4(9):e6902. doi: 10.1371/journal.pone.0006902.

13.

Sequential immunogene therapy with interleukin-12- and interleukin-15-engineered neuroblastoma cells cures metastatic disease in syngeneic mice.

Croce M, Meazza R, Orengo AM, Radić L, De Giovanni B, Gambini C, Carlini B, Pistoia V, Mortara L, Accolla RS, Corrias MV, Ferrini S.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):735-42.

14.

Neuroblastoma: management, recurrence, and follow-up.

Lee KL, Ma JF, Shortliffe LD.

Urol Clin North Am. 2003 Nov;30(4):881-90. Review.

PMID:
14680322
15.

The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification.

Hogarty MD.

Cancer Lett. 2003 Jul 18;197(1-2):173-9. Review.

PMID:
12880978
16.

The evolution of clinical molecular genetics. Neuroblastoma as a model tumor.

Israel MA.

Am J Pediatr Hematol Oncol. 1986 Summer;8(2):163-72. Review.

PMID:
3526938
17.

Genetically engineered mouse models of pancreatic cancer.

Westphalen CB, Olive KP.

Cancer J. 2012 Nov-Dec;18(6):502-10. doi: 10.1097/PPO.0b013e31827ab4c4. Review.

18.

Therapeutic targeting of miRNAs in neuroblastoma.

Stallings RL, Foley NH, Bryan K, Buckley PG, Bray I.

Expert Opin Ther Targets. 2010 Sep;14(9):951-62. doi: 10.1517/14728222.2010.510136. Review.

PMID:
20658962
19.

Neuroblastoma: biology, prognosis, and treatment.

Park JR, Eggert A, Caron H.

Pediatr Clin North Am. 2008 Feb;55(1):97-120, x. doi: 10.1016/j.pcl.2007.10.014. Review.

PMID:
18242317
20.

Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma.

Carlson LM, Rasmuson A, Idborg H, Segerström L, Jakobsson PJ, Sveinbjörnsson B, Kogner P.

Carcinogenesis. 2013 May;34(5):1081-8. doi: 10.1093/carcin/bgt009. Epub 2013 Jan 24.

PMID:
23349014

Supplemental Content

Support Center